ArticleOpen forum infectious diseases2022

Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.

Allison August et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.